Novonix Limited
NASDAQ:NVXElectrical Equipment & Parts
-$0.01 today
- Market cap
- $403.26M
- Beta
- 0.91
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$0.14
Volume 0.01M
Average 0.36M
NVX Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Novonix LimitedNASDAQ: NVX
Other Working Capital · Q4 FY2025 · quarter ended Dec 2025
Other working capital turns positive
Q4 FY2025 other working capital was $0, compared with -$501.11K a year earlier. Over 3 fiscal years it compounded at +44.2% a year.
Context
- Other working capital amounted to 75.6% of revenue in FY2025, up 68.5 pp from a year earlier.
- Other working capital increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
Mixed currencies · from the cash flow
- Latest · FY2025
- 4.25M USD
- Year-over-year change
- +1121.9%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.25M | +1121.9% |
| FY2024 | 2024-12-31 | (416K) | -139.3% |
| FY2023 | 2023-12-31 | 1.06M | -25.2% |
| FY2022 | 2022-12-31 | 1.42M | — |
| FY2021 | 2022-06-30 | 1.04M | — |
Other Working Capital vs competitors
How NVX compares with its peers on the latest reported figures
- Peers report in different currencies, so other working capital is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1121.9% is the highest of 11, against a peer median of -26.3%.
- Other working capital amounts to 75.6% of revenue for NVX, versus a peer median of 3.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $58.02M USD | -17.4% | +82.9% | 8.2% | |
| LTM Mar 2026 | $31.3M USD | -46.4% | +6.3% | 1.7% | |
PAMTPamt Corp. | LTM Mar 2026 | $19.1M USD | +168.2% | +44.8% | 3.3% |
| LTM Dec 2025 | $16.17M USD | -20.7% | — | — | |
SHMDSCHMID Group N.V. Class A Ordinary Shares | FY2025 | €9.71M EUR | +116.5% | +22.6% | 15.1% |
| LTM Apr 2026 | $6.25M USD | -32.0% | — | 3.7% | |
| FY2025 | $4.25M USD | +1121.9% | +44.2% | 75.6% | |
| LTM Mar 2026 | $3.58M USD | -193.3% | — | 273.1% | |
| LTM Mar 2026 | $2.04M USD | -90.6% | -24.3% | 0.5% | |
| LTM Mar 2026 | $1.51M USD | -52.7% | +58.2% | 1.6% | |
| LTM Mar 2026 | $1.29M USD | +128.3% | — | 6.9% | |
| Peer median (excluding NVX) | — | -26.3% | +33.7% | 3.7% | |
Competitors are the stored peer set for NVX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2022 · AUD | FY2022 Dec 2022 · USD | FY2023 Dec 2023 · USD | FY2024 Dec 2024 · USD | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Net Income | (51.86M) | (38.08M) | (46.25M) | (74.82M) | (92.79M) |
| Depreciation & Amortization | 4.21M | 3.57M | 4.74M | 4.57M | 4.57M |
| Deferred Income Tax | 2.79M | (4.91M) | 0 | 0 | 0 |
| Stock-Based Compensation | 14.68M | 0 | 3.83M | 5.52M | 0 |
| Change in Working Capital | 1.12M | 1.55M | 326.28K | 3.05M | 3.01M |
| Accounts Receivables | 0 | 158.79K | (567.85K) | 1.6M | 222.42K |
| Inventory | 166.18K | (945.58K) | 1.2M | 455.64K | (673.79K) |
| Accounts Payables | (90.69K) | 916.22K | (1.37M) | 1.42M | (787.04K) |
| Other Working Capital | 1.04M | 1.42M | 1.06M | (416K) | 4.25M |
| Other Non-Cash Items | (172.95K) | 24.81M | 1.13M | 21.26M | 42.98M |
| Operating Cash Flow | (29.23M) | (13.08M) | (36.23M) | (40.42M) | (42.23M) |
| Capital Expenditures | (83.79M) | (16.75M) | (19.2M) | (29.91M) | (60.22M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 1.32M |
| Purchases of Investments | (12.77M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (10.24M) | 419.47K | 7.95M | 11.73M | 26.02M |
| Investing Cash Flow | (106.8M) | (16.33M) | (11.74M) | (18.17M) | (32.88M) |
| Debt Repayment | 32.36M | (483.62K) | 29.33M | (1.73M) | 93.79M |
| Common Stock Issued | 150.97M | 2.8K | 338.33K | 28.82M | 17.43M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.64M) | (58.39K) | (354.91K) | (1.88M) | (1.24M) |
| Financing Cash Flow | 180.69M | (539.22K) | 29.31M | 25.21M | 109.98M |
| Effect of Forex Changes | (4.52M) | 712.26K | (1.67M) | (2.78M) | 5.26M |
| Net Change in Cash | 40.14M | (29.24M) | (20.33M) | (36.16M) | 40.13M |
| Free Cash Flow | (113.02M) | (29.65M) | (55.42M) | (70.32M) | (102.45M) |
Novonix Limited
NASDAQ:NVX
Intrinsic Alpha fair value
Locked
Current Price
$1.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.